Currently, infectious diseases are responsible for a quarter of all deaths across the globe. Scientists at Birmingham are carrying out research to understand these diseases, the spread of antibiotic resistance, and facilitate the development of new antibiotics.
With outstanding facilities, staff and a comprehensive approach, the University is the ideal place to tackle antibacterial resistance. The Institute of Microbiology and Infection (IMI) brings together leading experts from many different fields of microbiology. They are examining every aspect of the issue: from understanding the mechanics of antibacterial resistance to developing new drugs and vaccines that counteract it. All of the research carried out at the IMI is directed towards a single goal: developing new medical treatments that will overcome the scourge of infectious disease and bring hope and relief to people around the world.
Research is investigating how to improve diagnostic tests for illnesses to allow for more targeted use of antibiotics. This will ensure that current and future antibiotics are effective for longer, and that infections continue to be controlled during routine and major procedures.
The University is striving to develop new bacterial vaccines that protect against susceptible and resistant strains as well as simple problems like traveller’s diarrhoea and salmonella.
Scientists are searching for novel antibacterial agents that are desperately needed to overcome antibiotic resistance mechanisms.
How you can help
Email firstname.lastname@example.org, or make a donation today at www.bhamalumni.org/givenow.